对人工智能支持的干预措施进行范围审查,用于慢性风湿性疾病的非药物管理
Nirali Shah1, Alexis Castellanos1, Yen T Chen1
1University of Michigan, Ann Arbor, Michigan, USA.
Arthritis care & research
|July 14, 2025
概括
人工智能 (AI) 为慢性风湿性疾病提供了有希望的非药物干预措施,增强了教育和炼坚持. 然而,长期临床影响和症状管理需要进一步研究.
科学领域:
- 类风湿病学 类风湿病学
- 人工智能的人工智能
- 数字健康数字健康
背景情况:
- 慢性类风湿病影响全球数百万人,需要创新的非药物管理策略.
- 传统干预往往在坚持和长期有效性方面面临挑战.
- 人工智能 (AI) 提出了一种新的方法来支持患者的自我管理和治疗坚持.
研究的目的:
- 系统地审查和总结AI支持的非药物干预措施,用于慢性风湿性疾病的成年人.
- 详细介绍这些干预措施的组件,AI方法和证据基础.
- 评估人工智能干预对临床,心理和行为结果的影响.
主要方法:
- 在Embase,PubMed,Cochrane和Scopus数据库中进行全面的文献搜索.
- 包括所有类型的出版物和针对慢性风湿性疾病的成年人的干预设置.
- 数据提取研究特征,干预组件,人工智能方法和两位独立审查员的结果.
主要成果:
- 确定了15项人工智能支持的干预措施,主要针对骨关节炎 (73%),重点是教育和运动 (67%).
- 基于规则的专家系统 (40%) 是最常见的AI工具,其次是NLP (33%) 和机器学习 (27%).
- 干预措施显示了高的可用性,参与度和坚持性,在运动遵守,体育活动和症状方面有所改善,尽管长期可持续性不确定.
结论:
- 人工智能支持的干预措施显示出改善慢性风湿性疾病的教育,运动和行为指导的潜力.
- 有证据表明,AI工具具有很高的可用性和患者参与度.
- 人工智能干预对症状管理的长期临床影响仍然不确定,需要进一步研究.
相关概念视频
Rheumatic Heart Disease III: Medical Management
35
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
35
Rheumatic Heart Disease IV: Nursing Management
40
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
40
Inflammatory Bowel Disease IV: Pharmacological Management
198
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
198
Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K
Rheumatic Heart Disease I: Introduction
48
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
48
Myocarditis IV: Nursing Management
33
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
33


